Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
SIM0500 is a humanized trispecific antibody that targets GPRC5D, BCMA, and CD3
Increases speed to market for drug developers working on nucleic acid therapeutics
Subscribe To Our Newsletter & Stay Updated
